TAPUR - Calfa, Carmen
-
Investigator:
Carmen Calfa
Email
Coordinator: Carolina Troche
+1 (305) 2431481
IRB: 20170529
SDG: Breast Cancer
Disease Site(s): Breast,Colon,Kaposis sarcoma,Kidney,Larynx,Liver,Lymphoid Leukemia,Multiple,Multiple Myeloma,Non-Hodgkin Lymphoma,Pancreas,Prostate,Soft Tissue
Sponsor: ASCO
Enrolling Sites:
Aventura
Deerfield
Gables
Kendall
Plantation
SylvesterTitle: The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Eligibility Criteria - NCT02693535 *This information has been extracted from " www.clinicaltrials.gov"
20200056 - D'Amato Gina
-
Investigator:
Gina D'Amato
Email
Coordinator: Nailet Real Bestard
+1 (305) 2438173
IRB: 20200056
SDG: Bone and Soft Tissue Cancers
Disease Site(s): Anus,Bladder,Bones and Joints,Breast,Cervix Uteri,Colon,Esophagus,Kidney,Lip, Oral Cavity and Pharynx,Liver,Lung,Melanoma, skin,Other Digestive Organ,Other Urinary,Ovary,Prostate,Rectum,Small Intestine,Soft Tissue,Stomach,Thyroid
Sponsor: DECIPHERA
Enrolling Sites:
Sylvester
Title: A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor
Eligibility Criteria - NCT03069469 *This information has been extracted from " www.clinicaltrials.gov"
MATCH - Huang, Marilyn
-
Investigator:
Marilyn Huang
Email
Coordinator: Carolina Troche
+1 (305) 2431481
IRB: 20150671
SDG: Gynecologic Cancer
Disease Site(s): Cervix Uteri,Colon,Corpus Uteri,Kaposis sarcoma,Kidney,Larynx,Liver,Multiple Myeloma,Non-Hodgkin Lymphoma,Other Female Genital,Ovary,Pancreas,Prostate,Soft Tissue
Sponsor: ECOG
Enrolling Sites:
Coral Springs
Deerfield
Gables
Hollywood
Kendall
Plantation
SylvesterTitle: Molecular Analysis for Therapy Choice (MATCH)
Eligibility Criteria - NCT02465060 *This information has been extracted from " www.clinicaltrials.gov"
CPI-006-001 - Merchan, Jaime
-
Investigator:
Jaime Merchan
Email
Coordinator: Rakhi Modak
+1 (305) 2437387
IRB: 20180279
SDG: Prostate, Bladder, and Kidney Cancers
Disease Site(s): Bladder,Bones and Joints,Cervix Uteri,Colon,Corpus Uteri,Kidney,Lip, Oral Cavity and Pharynx,Lung,Lymphoid Leukemia,Non-Hodgkin Lymphoma,Pancreas,Prostate,Rectum,Soft Tissue
Sponsor: CP
Enrolling Sites:
Sylvester
Title: CPI-006-001: A Phase 1/1b Multicenter Study To Evaluate The Humanized Anti-CD 73 Antibody, CPI-006, As A Single Agent, In Combination WIith CPI-444, And In Combination With Pembrolizumab In Adult Subjects With Advanced Cancers
Eligibility Criteria - NCT03454451 *This information has been extracted from " www.clinicaltrials.gov"
RTX-240-01 - Merchan, Jaime
-
Investigator:
Jaime Merchan
Email
Coordinator: Isabel Fernandez
+1 (305) 2435486
IRB: 20200686
SDG: Prostate, Bladder, and Kidney Cancers
Disease Site(s): Multiple
Sponsor: Rubius Therapeutics
Enrolling Sites:
Sylvester
Title: PHASE 1/2 STUDY OF RTX-240 AS A MONOTHERAPY AND IN COMBINATION WITH PEMBROLIZUMAB
Eligibility Criteria - NCT04372706 *This information has been extracted from " www.clinicaltrials.gov"
20210890 - Merchan Jaime
-
Investigator:
Jaime Merchan
Email
Coordinator: Isabel Fernandez
+1 (305) 2435486
IRB: 20210890
SDG: Colorectal Cancer
Disease Site(s): Colon
Sponsor: Exelixis Pharmaceuticals
Enrolling Sites:
Deerfield
Gables
Plantation
SylvesterTitle: A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Eligibility Criteria - NCT03845166 *This information has been extracted from " www.clinicaltrials.gov"
20210470 - MINOCHA VINAY
-
Investigator:
VINAY MINOCHA
Email
Coordinator: Carla Montoya
IRB: 20210470
SDG: Colorectal Cancer
Disease Site(s): Colon,Rectum
Sponsor: Mirati
Enrolling Sites:
Deerfield
Gables
Kendall
Plantation
SylvesterTitle: A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy
Eligibility Criteria - NCT04793958 *This information has been extracted from " www.clinicaltrials.gov"
Tbio-6517-ITu-001 - Pimentel, Agustin
-
Investigator:
Agustin Pimentel
Email
Coordinator: Rakhi Modak
+1 (305) 2437387
IRB: 20200277
SDG: Colorectal Cancer
Disease Site(s): Multiple
Sponsor: TSB
Enrolling Sites:
Sylvester
Title: A Phase 1/2a, Multicenter, Open-label Trial of TBio-6517, an Oncolytic Vaccinia Virus, Administered Alone and in Combination with Pembrolizumab, in Patients with Advanced Solid Tumors
Eligibility Criteria - NCT04301011 *This information has been extracted from " www.clinicaltrials.gov"
20210855 - Pimentel Agustin
-
Investigator:
Agustin Pimentel
Email
Coordinator: Siudy Vasquez Escobar
+1 (305) 2432122 x62122
IRB: 20210855
SDG: Colorectal Cancer
Disease Site(s): Colon,Rectum
Sponsor: PFIZER
Enrolling Sites:
Aventura
Deerfield
Gables
Kendall
Plantation
SylvesterTitle: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METASTATIC BRAF V600E-MUTANT COLORECTAL CANCER
Eligibility Criteria - NCT04607421 *This information has been extracted from " www.clinicaltrials.gov"
20211061 - Pimentel Agustin
-
Investigator:
Agustin Pimentel
Email
Coordinator:
IRB: 20211061
SDG: Colorectal Cancer
Disease Site(s): Colon
Sponsor: BRISTOL-MYERS SQUIBB
Enrolling Sites:
Aventura
Deerfield
Gables
Kendall
Plantation
SylvesterTitle: A Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Metastatic Colorectal Cancers
Eligibility Criteria - NCT03377361 *This information has been extracted from " www.clinicaltrials.gov"
DECREASE - Portelance, Lorraine
-
Investigator:
Lorraine Portelance
Email
Coordinator: Samantha St. Armand
IRB: 20191276
SDG: Colorectal Cancer
Disease Site(s): Anus
Sponsor: ECOG
Enrolling Sites:
Deerfield
Gables
SylvesterTitle: A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Eligibility Criteria - NCT04166318 *This information has been extracted from " www.clinicaltrials.gov"
AMC-095 - Ramos, Juan Carlos
-
Investigator:
Juan Carlos Ramos
Email
Coordinator:
IRB: 20160656
SDG: Leukemia, Lymphoma, and Myeloma
Disease Site(s): Anus,Lip, Oral Cavity and Pharynx,Lung,Other Hematopoietic
Sponsor: AMC
Enrolling Sites:
Sylvester
Title: A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors with an Expansion Cohort in HIV Associated Solid Tumors
Eligibility Criteria - NCT02408861 *This information has been extracted from " www.clinicaltrials.gov"
RPL-001-16 - Rodriguez, Estelamari
-
Investigator:
Estelamari Rodriguez
Email
Coordinator: Yanel Diaz Caro
3052438227
IRB: 20180802
SDG: Bone and Soft Tissue Cancers
Disease Site(s): Bladder,Breast-Female,Colon,Melanoma, skin
Sponsor: REPLIMUNE
Enrolling Sites:
Sylvester
Title: RPL-001-16: An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors
Eligibility Criteria - NCT03767348 *This information has been extracted from " www.clinicaltrials.gov"
Anchor Study - Rosa-cunha, Isabella
-
Investigator:
Isabella Rosa-cunha
Email
Coordinator:
IRB: 20160316
SDG: Population Sciences
Disease Site(s): Anus
Sponsor: AMC
Enrolling Sites:
JMH
SylvesterTitle: ANCHOR: Anal Cancer Prevention StudyAnal Cancer/HSIL Outcomes Research Study
Eligibility Criteria - NCT02135419 *This information has been extracted from " www.clinicaltrials.gov"
20210943 - Sussman Daniel
-
Investigator:
Daniel Sussman
Email
Coordinator:
IRB: 20210943
SDG: Colorectal Cancer
Disease Site(s): Colon
Sponsor: Janssen
Enrolling Sites:
Sylvester
Title: A Phase 1b Study to Evaluate the Efficacy and Safety of JNJ-64251330, a Janus Kinase (JAK) Inhibitor, in Participants with Familial Adenomatous Polyposis
Eligibility Criteria - NCT05014360 *This information has been extracted from " www.clinicaltrials.gov"
SPN-00714 - Valdes, Frances
-
Investigator:
Frances Valdes
Email
Coordinator: Yanel Diaz Caro
3052438227
IRB: 20190673
SDG: Other
Disease Site(s): Breast,Colon,Esophagus,Kidney,Lung,Other Female Genital,Ovary,Stomach
Sponsor: MTEM
Enrolling Sites:
Sylvester
Title: A Phase 1 open-label, multicenter dose escalation study of MT-5111 in subjects with previously treated advanced HER2-positive solid tumors
Eligibility Criteria - NCT04029922 *This information has been extracted from " www.clinicaltrials.gov"
ATRC-101-A01 - Valdes, Frances
-
Investigator:
Frances Valdes
Email
Coordinator: Yanel Diaz Caro
3052438227
IRB: 20200938
SDG: Other
Disease Site(s): Breast,Colon,Lung,Melanoma, skin,Ovary
Sponsor: Atreca Inc
Enrolling Sites:
Sylvester
Title: A Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 as Monotherapy and in Combination with Other Anticancer Agents in Adults with Advanced Solid Malignancies
Eligibility Criteria - NCT04244552 *This information has been extracted from " www.clinicaltrials.gov"